Science Explorer Interactive view Map
Company · Lehi · United States

Tolero Pharmaceuticals (United States)

toleropharma.comROR OpenAlex
Research works
56
▲ 3% vs 2013–17
Citations
598
10.6 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
11%
world 28%

Not ranked overall: Tolero Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Tolero Pharmaceuticals (United States)?

Ranked on the composite score, David J. Bearss and Steven L. Warner lead among researchers whose main affiliation is Tolero Pharmaceuticals (United States).

  1. 1 David J. Bearss United States · #441,953 worldwide 69 citations · 27 works
  2. 2 Steven L. Warner United States · #1,406,601 worldwide 5 citations · 32 works
All ranked researchers at Tolero Pharmaceuticals (United States)

Which keywords describe research at Tolero Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Macrophages, apoptotic cells, CD47, Tumor Microenvironment, Immunotherapy, Prognostic Factors and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy7▲ 90×2 topics
  2. Macrophages7▲ 76×2 topics
  3. CD477▲ 783×1 topic
  4. apoptotic cells7▲ 783×1 topic
  5. Tumor Microenvironment6▲ 29×4 topics
  6. Immunotherapy6▲ 15×6 topics
  7. Prognostic Factors5▲ 21×4 topics
  8. Cancer Therapy5▲ 15×8 topics
  9. Chemotherapy5▲ 12×7 topics
  10. Cancer4▲ 5.6×13 topics
  11. Metastasis4▲ 20×4 topics
  12. Cancer Progression4▲ 28×2 topics
  13. Chronic Lymphocytic Leukemia4▲ 128×1 topic
  14. Genomic Aberrations4▲ 128×1 topic
  15. Pancreatic Cancer3▲ 48×1 topic
  16. Surgical Complications3▲ 77×1 topic
  17. Pim Oncogenes3▲ 307×1 topic
  18. Tumorigenesis3▲ 100×1 topic
  19. Mutation3▲ 34×2 topics
  20. Transcriptional Regulation3▲ 20×4 topics
  21. Breast Cancer3▲ 17×3 topics
  22. Apoptosis3▲ 12×2 topics
  23. Metastatic Breast Cancer2▲ 67×2 topics
  24. CDK4/6 Inhibitors2▲ 268×1 topic
  25. Clinical Trials2▲ 6.9×7 topics
  26. Epigenetic Regulation2▲ 20×2 topics
  27. Palbociclib2▲ 268×1 topic
  28. BET Bromodomains2▲ 198×1 topic
  29. PROTACs2▲ 198×1 topic
  30. Regulation2▲ 6.6×3 topics
  31. Proteasome Inhibitors2▲ 52×2 topics
  32. Staging System2▲ 55×2 topics
  33. Cell Cycle2▲ 60×1 topic
  34. Genetic Mutations2▲ 6.5×3 topics
  35. Tumor Hypoxia2▲ 38×2 topics
  36. p532▲ 79×1 topic
  37. AML2▲ 69×1 topic
  38. Acute Myeloid Leukemia2▲ 69×1 topic
  39. HIF-12▲ 43×1 topic
  40. Hormone Therapy2▲ 29×2 topics

Which research topics does Tolero Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Hormonal Regulation and Hypertension, Prostate Cancer Treatment and Research, Chemotherapy-induced cardiotoxicity and mitigation and Cancer, Lipids, and Metabolism.

Hormonal Regulation and Hypertension: 0 fractional worksProstate Cancer Treatment and Research: 0 fractional worksChemotherapy-induced cardiotoxicity and mitigation: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksOvarian cancer diagnosis and treatment: 0 fractional worksHormonal and reproductive studies: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksCardiac Imaging and Diagnostics: 0 fractional worksCardiac Health and Mental Health: 0 fractional worksOvarian function and disorders: 0 fractional works
Endocrinology, Diabetes and MetabolismPulmonary and Respiratory MedicineCardiology and Cardiovascular MedicineCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  3. 3 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
  4. 4 Cancer, Lipids, and Metabolism Cancer Research 0 works
  5. 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  6. 6 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  8. 8 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Cardiac Health and Mental Health Cardiology and Cardiovascular Medicine 0 works
  10. 10 Ovarian function and disorders Reproductive Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available11.4%not open88.6%

World: 28% of research is openly available.

with international co-authors7.5%domestic only92.5%

World: 19% is written across borders.

How has Tolero Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 3% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lehi

All research institutions in Lehi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.